Amgen, Inc. (NASDAQ:AMGN) – Stock analysts at Piper Jaffray Companies raised their Q1 2020 earnings per share estimates for Amgen in a report released on Thursday, July 11th. Piper Jaffray Companies analyst C. Raymond now forecasts that the medical research company will post earnings per share of $3.56 for the quarter, up from their previous forecast of $3.55.

Nucor Co. (NYSE:NUE) – Equities researchers at KeyCorp issued their Q3 2019 earnings per share (EPS) estimates for shares of Nucor in a report released on Monday, June 17th, Zacks Investment Research reports. KeyCorp analyst P. Gibbs anticipates that the basic materials company will post earnings per share of $1.17 for the quarter. KeyCorp has a “Overweight” rating and a $61.00 price target on the stock. KeyCorp also issued estimates for Nucor’s Q4 2019 earnings at $1.15 EPS and FY2020 earnings at $4.26 EPS.

Hancock Whitney Corp (NYSE:HWC) – Equities research analysts at SunTrust Banks cut their Q2 2019 earnings per share estimates for Hancock Whitney in a research report issued to clients and investors on Thursday, June 27th, Zacks Investment Research reports. SunTrust Banks analyst J. Demba now expects that the company will post earnings of $1.01 per share for the quarter, down from their prior forecast of $1.02. SunTrust Banks also issued estimates for Hancock Whitney’s Q3 2019 earnings at $1.01 EPS, Q4 2019 earnings at $1.08 EPS, FY2019 earnings at $4.09 EPS and Q4 2020 earnings at $1.12 EPS.

Vericel Corp (NASDAQ:VCEL) – Svb Leerink decreased their Q2 2019 earnings estimates for shares of Vericel in a report issued on Wednesday, June 19th, Zacks Investment Research reports. Svb Leerink analyst D. Antalffy now forecasts that the biotechnology company will earn ($0.47) per share for the quarter, down from their prior estimate of ($0.08). Svb Leerink also issued estimates for Vericel’s Q3 2019 earnings at $0.00 EPS, FY2019 earnings at ($0.34) EPS, Q1 2020 earnings at ($0.04) EPS and FY2020 earnings at $0.26 EPS.

Fresenius Medical Care AG & Co. (NYSE:FMS) – Analysts at SunTrust Banks issued their Q1 2020 earnings per share (EPS) estimates for Fresenius Medical Care AG & Co. in a research note issued on Tuesday, June 25th, Zacks Investment Research reports. SunTrust Banks analyst D. Macdonald forecasts that the company will earn $0.59 per share for the quarter. SunTrust Banks also issued estimates for Fresenius Medical Care AG & Co.’s Q2 2020 earnings at $0.63 EPS, Q3 2020 earnings at $0.65 EPS and Q4 2020 earnings at $0.71 EPS.

Cintas Co. (NASDAQ:CTAS) – Investment analysts at William Blair raised their Q1 2020 earnings estimates for Cintas in a research note issued on Thursday, June 20th, Zacks Investment Research reports. William Blair analyst T. Mulrooney now anticipates that the business services provider will post earnings of $1.97 per share for the quarter, up from their previous estimate of $1.89. William Blair has a “Buy” rating on the stock. William Blair also issued estimates for Cintas’ Q3 2020 earnings at $1.87 EPS and Q4 2020 earnings at $2.30 EPS.

CARREFOUR SA/S (OTCMKTS:CRRFY) – Analysts at Jefferies Financial Group lifted their FY2019 earnings per share estimates for CARREFOUR SA/S in a research report issued to clients and investors on Wednesday, June 26th, according to Zacks Investment Research. Jefferies Financial Group analyst J. Grzinic now forecasts that the company will post earnings of $0.25 per share for the year, up from their prior estimate of $0.24. Jefferies Financial Group also issued estimates for CARREFOUR SA/S’s FY2020 earnings at $0.27 EPS and FY2021 earnings at $0.28 EPS.

Rosetta Stone Inc (NYSE:RST) – Analysts at Barrington Research cut their Q2 2019 EPS estimates for shares of Rosetta Stone in a research report issued on Monday, June 17th, Zacks Investment Research reports. Barrington Research analyst A. Paris. Jr now expects that the software maker will post earnings of ($0.31) per share for the quarter, down from their prior forecast of ($0.17). Barrington Research currently has a “Buy” rating and a $29.00 target price on the stock. Barrington Research also issued estimates for Rosetta Stone’s Q3 2019 earnings at ($0.16) EPS, Q4 2019 earnings at ($0.15) EPS and FY2019 earnings at ($0.64) EPS.

Cellular Biomedicine Group Inc (NASDAQ:CBMG) – Analysts at Cantor Fitzgerald issued their FY2019 earnings per share estimates for Cellular Biomedicine Group in a research report issued to clients and investors on Tuesday, June 25th, according to Zacks Investment Research. Cantor Fitzgerald analyst V. Kumar forecasts that the biotechnology company will post earnings of ($2.05) per share for the year. Cantor Fitzgerald currently has a “Overweight” rating and a $27.00 target price on the stock. Cantor Fitzgerald also issued estimates for Cellular Biomedicine Group’s FY2020 earnings at ($2.05) EPS.

Prestige Consumer Healthcare Inc (NYSE:PBH) – Jefferies Financial Group upped their Q1 2020 earnings estimates for Prestige Consumer Healthcare in a note issued to investors on Tuesday, June 25th, according to Zacks Investment Research. Jefferies Financial Group analyst S. Wissink now anticipates that the company will post earnings of $0.65 per share for the quarter, up from their prior forecast of $0.61. Jefferies Financial Group also issued estimates for Prestige Consumer Healthcare’s Q3 2020 earnings at $0.78 EPS.